Report available on clinical decision support tool to assess patients' risk for deleterious BRCA mutations
Research Activities, February 2011, No. 366
The Effective Health Care Program of the Agency for Healthcare Research and Quality recently released a new technical report, A Primary Care-Focused, Computer-based Clinical Decision Support Tool to Assess Patients' Risk for Deleterious BRCA Mutations. These mutations are linked to hereditary breast and ovarian cancer. The report, conducted by the RTI International DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) Center, describes development of a clinical decision support tool that could be used to screen for risk of BRCA mutations in primary care settings. The tool could also assist in the implementation of the U.S. Preventive Services Task Force recommendations regarding referrals for genetic counseling and evaluation for BRCA1 and BRCA2 genes. The first version of the BRCA clinical decision support tool is not considered ready for clinical use, but is available to researchers, upon request, for further evaluation and modification.